Left ventricular diastolic dyfunction detection is particularly important in cardiac function screening. This paper proposed a phonocardiogram (PCG) transfer learning-based CatBoost model to detect diastolic dysfunction noninvasively. The Short-Time Fourier Transform (STFT), Mel Frequency Cepstral Coefficients (MFCCs), S-transform and gammatonegram were utilized to perform four different representations of spectrograms for learning the representative patterns of PCG signals in two-dimensional image modality. Then, four pre-trained convolutional neural networks (CNNs) such as VGG16, Xception, ResNet50 and InceptionResNetv2 were employed to extract multiple domain-specific deep features from PCG spectrograms using transfer learning, respectively. Further, principal component analysis and linear discriminant analysis (LDA) were applied to different feature subsets, respectively, and then these different selected features are fused and fed into CatBoost for classification and performance comparison. Finally, three typical machine learning classifiers such as multilayer perceptron, support vector machine and random forest were employed to compared with CatBoost. The hyperparameter optimization of the investigated models was determined through grid search. The visualized result of the global feature importance showed that deep features extracted from gammatonegram by ResNet50 contributed most to classification. Overall, the proposed multiple domain-specific feature fusion based CatBoost model with LDA achieved the best performance with an area under the curve of 0.911, accuracy of 0.882, sensitivity of 0.821, specificity of 0.927, F1-score of 0.892 on the testing set. The PCG transfer learning-based model developed in this study could aid in diastolic dysfunction detection and could contribute to non-invasive evaluation of diastolic function.
Background: Heart failure (HF) is a type of cardiovascular disease caused by abnormal cardiac structure and function. Early screening of HF has important implication for treatment in a timely manner. Heart sound (HS) conveys relevant information related to HF; this study is therefore based on the analysis of HS signals. The objective is to develop an efficient tool to identify subjects of normal, HF with preserved ejection fraction and HF with reduced ejection fraction automatically. Methods: We proposed a novel HF screening framework based on gated recurrent unit (GRU) model in this study. The logistic regression-based hidden semi-Markov model was adopted to segment HS frames. Normalized frames were taken as the input of the proposed model which can automatically learn the deep features and complete the HF screening without de-nosing and hand-crafted feature extraction. Results: To evaluate the performance of proposed model, three methods are used for comparison. The results show that the GRU model gives a satisfactory performance with average accuracy of 98.82%, which is better than other comparison models. Conclusion: The proposed GRU model can learn features from HS directly, which means it can be independent of expert knowledge. In addition, the good performance demonstrates the effectiveness of HS analysis for HF early screening.
Poor drug delivery to solid tumors remains a great challenge for effective antitumor therapy. Herein, multistage stimuli-responsive nanovectors based on hollow mesoporous silica nanoparticles (HMSNs) were prepared to avoid delivery barriers for improved penetration and programmed tumor therapy. The versatile nanosystem was constructed through electrostatic complexation between the functional HMSNs loaded with gemcitabine (GEM) and the small-sized platinum prodrug-conjugated poly(amidoamine) dendrimer (PAMAM-Pt). The HMSNs were functionalized with dimethylmaleic anhydride tethered chitosan oligosaccharide to endow the particles of HMSN-CS(DMA) with charge-reversal properties. The as-prepared nanosystem had a stable structure of size ∼130 nm at pH 7.4, which is beneficial for blood circulation and tumor vessel extravasation of nanocarriers. Once it reaches the tumor site, the nanosystem can dissociate into HMSN@GEM-CS (∼120 nm) and PAMAM-Pt dendrimer nanocarriers (∼5 nm) in response to the acidic tumor microenvironment because of the acid-mediated charge-reversal, then the HMSN@GEM can play the antitumor role in surface tumor tissues. The dissociated PAMAM-Pt showed excellent performance in tumor penetration, cell uptake and intracellular trafficking due to the small size and positive charge, which was supported by the study of three-dimensional multicellular spheroids in vitro. Finally, the active cisplatin was released from the PAMAM-Pt dendrimer under the intracellular reducing environment to kill cells in deep tumor tissues. The significant tumor suppression of this system in vivo was validated in the A549 tumor xenografted mouse model. Such a stimuli-responsive nanosystem that integrates simple preparation, biocompatibility, biodegradability and programmed tumor therapy manifests great potential for clinical trials.